BALL-1 Cells

The BALL-1 cell line originates from a 75-year-old male patient diagnosed with acute lymphoblastic leukemia (ALL). Established from the peripheral blood, this cell line is of particular interest due to the patient's advanced age, offering a unique perspective on the disease in elderly populations. BALL-1 cells exhibit characteristics of B-cell lineage, notably expressing markers such as CD19 and CD10. These cells are negative for surface immunoglobulin, aligning with phenotypes observed in early stages of B-cell neoplastic development. As a model, BALL-1 is pivotal for researching the pathogenesis of B-cell leukemia, particularly within older patients, where disease dynamics may differ significantly from those observed in younger individuals. This cell line facilitates the exploration of molecular and cellular mechanisms underlying leukemia progression, therapeutic resistance, and the emergence of new drug targets. BALL-1 is instrumental in drug discovery and testing, aiding in the assessment of new anti-leukemic compounds. Moreover, the genetic abnormalities present in BALL-1 provide essential insights into the chromosomal alterations involved in the pathogenesis of B-cell precursor acute lymphoblastic leukemia. Leukemia cell lines, B Lymphocyte, B-cell acute lymphoblastic leukemia, Growth Conditions: Suspension, Biosafety level: BSL 1